Please login to the form below

Not currently logged in
Email:
Password:

Ablynx

This page shows the latest Ablynx news and features for those working in and with pharma, biotech and healthcare.

Second TULIP trial resurrects AZ’s lupus drug anifrolumab

Second TULIP trial resurrects AZ’s lupus drug anifrolumab

dapirolizumab pegol, Ablynx’ IL-6 inhibitor vobarilizumab, and ImmuPharma’s immune modulator rigerimod.

Latest news

More from news
Approximately 8 fully matching, plus 34 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • PureTech Health appoints new chief financial officer PureTech Health appoints new chief financial officer

    Muijrers has worked with pharmaceutical clients such as Kite Pharma, Ablynx and Juno Therapeutics, and said: “I am thrilled to join PureTech Health, one of the most exiciting and unique biopharma

  • Apitope strengthens its board with new director Apitope strengthens its board with new director

    He has also served on several boards including Ablynx, Evotec and Acambis.

  • Ablynx reshuffles its board again Ablynx reshuffles its board again

    Dr Greig has been non-executive director of Ablynx since 2012, and has been unanimously elected by the board to be the biotech’s new chairman. ... Dr Edwin Moses, chief executive officer of Ablynx, said: “We are very fortunate to have a very suitable

  • Robert Freisen joins Ablynx Robert Freisen joins Ablynx

    Ablynx, recently acquired by Sanofi, has appointed Robert Freisen to the role of chief scientific officer, who will head the biopharma’s scientific research and technology activities. ... He said: “I have long admired Ablynx and am excited to join

  • Novo Nordisk target Ablynx reshuffles its board Novo Nordisk target Ablynx reshuffles its board

    Biopharmaceutical group Ablynx has made some changes to its board of directors after recently declining a takeover proposal for the second time from Novo Nordisk. ... Heading up the board is Ablynx’s non-executive director Dr Bo Jesper Hensen (pictured)

More from appointments
Approximately 5 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics